Published November 16, 2023
| Version v1
Journal article
Open
The design and virtual screening of thiourea derivatives as a Sirtuin-1 inhibitor
Authors/Creators
- 1. Universitas Bakti Tunas Husada, Tasikmalaya, Indonesia
- 2. Universitas Perjuangan Tasikmalaya, Tasikmalaya, Indonesia
- 3. Universitas Indonesia, Jakarta, Indonesia
Description
The SIRT1 is overexpressed in a number of cancers. As a result, inhibiting SIRT1 may be used as a cancer treatment technique. Modification of 1-benzoyl-3-methylthiourea derivatives was carried out in this study by changing the aromatic side. The designed compounds (94) were subjected to in silico docking, pharmacokinetics, and preclinical testing. In the docking sample, the (4-decyl-N-(methylcarbamothioyl)benzamide (91), 2-(benzyloxy)-N-(methylcarbamo-thioyl)benzamide (93) and N-(methylcarbamothioyl)-2-naphthamide (94) were predicted to display better inhibition of SIRT1, so they were chosen for subsequent molecular dynamic studies. The compound 93 is proposed as a possible anticancer candidate that inhibits SIRT1 based on the screening results from molecular docking, pharmacokinetic predictions, and molecular dynamics.
Files
PHAR_article_108012.pdf
Files
(2.2 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bae8b2b7be433831f8ed37bb1c670085
|
2.1 MB | Preview Download |
|
md5:9e98e8486b03a3ea46aeb2822966fd24
|
109.1 kB | Preview Download |
Additional details
References
- Adelin T (2013) Penambatan molekuler kurkumin dan analognya pada enzim siklooksigenase-2. Jurnal Medika Veterinaria 7(1): 30–34.
- Aromatic O, Carcinogens A (1972) Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. PNAS 69(11): 3128–3132. https://doi.org/10.1073/pnas.69.11.3128
- De Beer TAP, Berka K, Thornton JM, Laskowski RA (2014) PDBsum additions. Nucleic Acids Research 42: 292–296. https://doi.org/10.1093/nar/gkt940
- Bosch-Presegué L, Vaquero A (2011) The dual role of sirtuins in cancer. Genes & Cancer 2: 648–662. https://doi.org/10.1177/1947601911417862
- Carafa V, Altucci L, Nebbioso A (2019) Dual tumor suppressor and tumor promoter action of sirtuins in determining malignant phenotype. Frontiers in Pharmacology 10: 1–14. https://doi.org/10.3389/fphar.2019.00038
- Chastagner P, Sudour H, Mriouah J, Barberi-Heyob M, Bernier-Chastagner V, Pinel S (2015) Preclinical studies of pegylated- and non-pegylated liposomal forms of doxorubicin as radiosensitizer on orthotopic high-grade glioma xenografts. Pharmaceutical Research 32: 158–166. https://doi.org/10.1007/s11095-014-1452-x
- Chi S, Ohue M, Gryniukov A, Borysko P et al. (2019) A prospective compound screening contest identified broader inhibitors for Sirtuin 1. Scientific Reports 9: 19585. https://doi.org/10.1038/s41598-019-55069-y
- Choi G, Lee J, Ji JY, Woo J, Kang NS, Cho SY, Kim HR, Ha JD, Han S-Y (2013) Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects. International Journal of Oncology 43(4): 1205–1211. https://doi.org/10.3892/ijo.2013.2035
- Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules. Scientific Reports 7: 42717 https://doi.org/10.1038/srep42717
- Erlina L, Yanuar A (2018) Molecular dynamics simulation of SIRT1 inhibitor from indonesian herbal database. Journal of Young Pharmacists 10(1): 3–6. https://doi.org/10.5530/jyp.2018.10.2
- Gertz M, Fischer F, Thi G, Nguyen T, Lakshminarasimhan M, Schutkowski M, Weyand M, Steegborn C (2013) Ex-527 inhibits Sirtuins by exploiting their unique NAD + -dependent deacetylation mechanism. PNAS 110(30): E2772–E2781. https://doi.org/10.1073/pnas.1303628110
- Hariono M, Nuwarda RF, Yusuf M, Rollando R, Jenie RI, Al-Najjar B, Julianus J, Putra KC, Nugroho ES, Wisnumurti YK, Dewa SP, Jati BW, Tiara R, Ramadani RD, Qodria L, Wahab HA (2020) Arylamide as potential selective inhibitor for matrix metalloproteinase 9 (MMP9): design, synthesis, biological evaluation, and molecular modeling. Journal of Chemical Information and Modeling 60: 349–359. https://doi.org/10.1021/acs.jcim.9b00630
- Koushik V, Alvala M, Saketh D, Viswanadha S, Sriram D, Yogeeswari P (2014) Structure-based drug design of small molecule SIRT1 modulators to treat cancer and metabolic disorders. Journal of Molecular Graphics and Modelling 52: 46–56. https://doi.org/10.1016/j.jmgm.2014.06.005
- Kozako T, Suzuki T, Yoshimitsu M, Arima N, Honda S, Soeda S (2014) Anticancer agents targeted to sirtuins. Molecules 19(12): 20295–20313. https://doi.org/10.3390/molecules191220295
- Lanevskij K, Dapkunas J, Juska L, Japertas P, Didziapetris R (2011) QSAR analysis of blood – brain distribution: the influence of plasma and brain tissue binding. Journal of Pharmaceutical Sciences 100(6): 2147–2160. https://doi.org/10.1002/jps.22442
- Lee HN, Jang HY, Kim HJ, Shin SA, Choo GS, Park YS, Kim SK, Jung JY (2016) Antitumor and apoptosis-inducing effects of α -mangostin extracted from the pericarp of the mangosteen fruit (Garcinia mangostana L .) in YD-15 tongue mucoepidermoid carcinoma cells. International Journal of Molecular Medicine 37(4): 939–948. https://doi.org/10.3892/ijmm.2016.2517
- Li H, Li H, Qu H, Zhao M, Yuan B, Cao M, Cui J (2015) Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression. Cancer Cell International 15: 1–11. https://doi.org/10.1186/s12935-015-0196-y
- Lilly E (2011) Sirtuin 1 (SIRT1): The Misunderstood HDAC. SLAS Discovery 16(10): 1153–1169. https://doi.org/10.1177/1087057111422103
- Ma W, Zhao X, Wang K, Liu J, Huang G (2018) Dichloroacetic acid (DCA) synergizes with the SIRT2 inhibitor Sirtinol and AGK2 to enhance anti-tumor efficacy in non-small cell lung cancer. Cancer Biology & Therapy 19: 835–846. https://doi.org/10.1080/15384047.2018.1480281
- Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser K, Simmerling C (2015) ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation 11(8): 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255
- Mardianingrum R, Endah SRN, Suhardiana E, Ruswanto R, Siswandono S (2021) Docking and molecular dynamic study of isoniazid derivatives as anti-tuberculosis drug candidate. Chemical Data Collections 32: 100647. https://doi.org/10.1016/j.cdc.2021.100647
- Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. Software News and Updates 30(16): 2785–2791. https://doi.org/10.1002/jcc.21256
- Muchtaridi M, Yusuf M, Syahidah HN, Subarnas A, Zamri A, Bryant SD, Langer T (2019) Cytotoxicity of chalcone of eugenia aquea burm F. leaves against T47D breast cancer cell lines and its prediction as an estrogen receptor antagonist based on pharmacophore-molecular dynamics simulation. Advances and Applications in Bioinformatics and Chemistry 12: 33–43. https://doi.org/10.2147/AABC.S217205
- Nebbioso A, Pereira R, Khanwalkar H, Matarese F, García-Rodríguez J, Miceli M, Logie C, Kedinger V, Ferrara F, Stunnenberg HG, de Lera AR, Gronemeyer H, Altucci L (2011) Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. Molecular Cancer Therapeutics 10(12): 2394–2404. https://doi.org/10.1158/1535-7163.MCT-11-0525
- Pal S, Kumar V, Kundu B, Bhattacharya D, Preethy N, Reddy MP, Talukdar A (2019) Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors. Computational and Structural Biotechnology Journal 17: 291–310. https://doi.org/10.1016/j.csbj.2019.02.006
- Park EY, Woo Y, Kim SJ, Kim DH, Lee EK, De U, Kim KS, Lee J, Jung JH, Ha K, Choi WS, Kim IS, Lee BM, Yoon S, Moon HR, Kim HS (2016) Anticancer effects of a new SIRT inhibitor, MHY2256, against human breast cancer MCF-7 cells via regulation of MDM2-p53 binding. International Journal of Biological Sciences 12(12): 1555–1567. https://doi.org/10.7150/ijbs.13833
- Prajapat R, Marwal A, Gaur RK (2014) Recognition of errors in the refinement and validation of three-dimensional structures of AC1 proteins of begomovirus strains by using ProSA-Web. Journal of Viruses 2014: 752656. https://doi.org/10.1155/2014/752656
- Qidwai T, Yadav DK, Khan F, Dhawan S, Bhakuni RS (2012) QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Current Pharmaceutical Design 18(37): 6133–6154. https://doi.org/10.2174/138161212803582397
- Qin Z, Kastrati I, Chandrasena REP, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GRJ (2007) Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity. Journal of Medicinal Chemistry 50(11): 2682–2692. https://doi.org/10.1021/jm070079j
- Ruswanto , Miftah AM, Tjahjono DH (2015) Synthesis and in vitro cytotoxicity of 1-benzoyl-3-methyl thiourea derivatives. Procedia Chemistry 17: 157–161. https://doi.org/10.1016/j.proche.2015.12.105
- Ruswanto , Siswandono , Richa M, Tita N, Tresna L (2017) Molecular docking of 1-benzoyl-3-methylthiourea as anti cancer candidate and its absorption, distribution, and toxicity prediction. Journal of Pharmaceutical Sciences and Research 9(5): 680–684.
- Ruswanto R, Mardianingrum R, Siswandono S, Kesuma D (2020) Reverse docking, molecular docking, absorption, distribution, and toxicity prediction of artemisinin as an anti-diabetic candidate. Molekul 15: 88–96. https://doi.org/10.20884/1.jm.2020.15.2.579
- Ruswanto R, Garna IM, Tuslinah L, Mardianingrum R, Lestari T, Nofianti T (2018) Kuersetin, penghambat uridin 5-monofosfat sintase sebagai kandidat anti-kanker. ALCHEMY Jurnal Penelitian Kimia 14(2): 236–252. https://doi.org/10.20961/alchemy.14.2.14396.236-254
- Salomon-ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. WIREs Computational Molecular Science 3(2): 198–210. https://doi.org/10.1002/wcms.1121
- Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, der Valk MA, Robanus-Maandag EC, Riele HPJ, Berns AJM, Borst P (1994) Disruption of the mouse m & la P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77(4): 491–502. https://doi.org/10.1016/0092-8674(94)90212-7
- Shibata T, Yamagata T, Kawade A, Asakura S, Toritsuka N, Koyama N, Hakura A (2020) Evaluation of acetone as a solvent for the Ames test. Genes and Environment 42: 1–8. https://doi.org/10.1186/s41021-020-0143-6
- Sonnemann J, Kahl M, Siranjeevi PM, Blumrich A, Blümel L, Becker S, Wittig S, Winkler R, Krämer OH, Beck JF (2015) Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing ' s sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide – and vincristine – induced anticancer activity. Journal of Cancer Research and Clinical Oncology 142: 17–26. https://doi.org/10.1007/s00432-015-1994-2
- Sun Y, Zhou H, Zhu H, Leung S (2016) Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products. Scientific Reports 6: 19312. https://doi.org/10.1038/srep19312
- Tan YJ, Lee YT, Yeong KY, Petersen SH, Kono K, Tan SC, Oon CE (2018) Anticancer activities of a benzimidazole compound through sirtuin inhibition in colorectal cancer. Future Medicinal Chemistry 10(17). https://doi.org/10.4155/fmc-2018-0052
- Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions Clean up structure. Protein Engineering, Design and Selection 8(2): 127–134. https://doi.org/10.1093/protein/8.2.127
- Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research 35(suppl_2): W407–W410. https://doi.org/10.1093/nar/gkm290
- Wössner N, Alhalabi Z, González J, Swyter S, Gan J, Sippl W, Jung M (2020) Sirtuin 1 inhibiting thiocyanates (S1th) – A new class of isotype selective inhibitors of NAD + dependent lysine deacetylases. Frontiers in Oncology 10: 1–15. https://doi.org/10.3389/fonc.2020.00657
- Zhang WEI, Yang R, Cieplak P, Luo RAY, Lee T, Caldwell J, Wang J, Kollman P (2003) A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase. Journal of Computational Chemistry 24(16): 1999–2012. https://doi.org/10.1002/jcc.10349
- Zhao X, Allison D, Condon B, Zhang F, Gheyi T, Zhang A, Ashok S, Russell M, Macewan I, Qian Y, Jamison JA, Luz JG (2013) The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD +) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition. Journal of Medicinal Chemistry 56(3): 963–969. https://doi.org/10.1021/jm301431y
- Zhou AQ, Hern CSO, Regan L (2011) Revisiting the Ramachandran plot from a new angle. Protein Science 20(7): 1166–1171. https://doi.org/10.1002/pro.644